Trial intelligence / Profile preview

Desloratadine Quality of Life Study in Chronic Urticaria

NCT00795158Phase 3Completed

Sponsor
Organon & Co.
Start
Nov 2002
Primary completion
Jan 2004
Modality
Small Molecules
01

Overview

A Phase 3 trial of desloratadine in chronic urticaria (CU), sponsored by Organon & Co.. Started Nov 2002; status: completed.

02

Drugs

desloratadine
03

Conditions

chronic urticaria (CU)

Beyond the preview

Go deeper on NCT00795158.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00795158.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call